1) The document describes a prototype endoscopic suturing system that allows full-thickness suturing of the stomach wall for closure of openings (gastrotomies) during natural orifice translumenal endoscopic surgery (NOTES).
2) In vitro tests on isolated pig stomachs showed the system could accurately place running sutures in a pursestring configuration to securely close an 18mm gastrotomy with no leaks.
3) Edge-to-edge closure of gastotomies was also achieved in a leak-proof manner during single intubations using the suturing system.
This document discusses the advantages of physician-led hospitals and why physicians must lead in healthcare. It provides examples showing that the top-rated hospitals like Mayo Clinic and Cleveland Clinic have been led by physicians for over 100 years. Physician leadership results in better patient outcomes, satisfaction, economic performance, and physician retention and satisfaction. Studies show physician-led hospitals score higher on quality metrics than non-clinician led hospitals. The document argues physicians possess credibility as leaders since they understand clinical practice from experience. It also discusses the challenges of physician burnout and need for training clinical leaders to succeed in today's team-based healthcare system.
This study evaluated the technical feasibility and safety of using a novel endoscopic suturing device to repair gastrointestinal fistulae in 7 patients. The procedure was technically successful in all patients with no early complications. At follow up of 5.1 months, 6 patients had resolution of symptoms and average weight loss of 22.8 pounds. While the study was limited by its small size and short follow up, the results suggest endoscopic repair of fistulae using this suturing device can be achieved safely and warrants further study.
This document summarizes the market for obesity products and treatments. It discusses how the field is moving "back to basics" to better understand the physiological mechanisms behind obesity and weight loss. This new understanding may help develop more effective minimally invasive solutions. The US market for minimally invasive bariatric devices is expected to grow moderately over the next five years, reaching over $500 million by 2016, driven by factors like the growing obese population. However, current treatment options have only achieved limited success in treating obesity.
This document provides details about an upcoming symposium on endosurgery to be held on September 19th, 2011 at the Apollo Hospital in New Delhi. The symposium will focus on flexible surgery techniques that minimize surgical trauma through natural orifices. Experts will present on robotics, endoscopic stitching and resection devices. The program will include training discussions on weight regain after bariatric surgery and a debate on surgical versus endoscopic solutions. Equipment demonstrations and a panel discussion on the future of endosurgery in India are also included. Attendees should include doctors from Apollo hospitals with expertise in gastroenterology, bariatrics, and endocrinology.
Flyer for one day seminar for surgeons and gastroenterologists showcasing innovative technologies in endosurgery and robotic surgery
Sept 19, 2011 New Delhi
This study examined whether placing a biologic mesh during abdominal closure would reduce the risk of developing an incisional hernia compared to primary closure without mesh in high-risk patients undergoing gastric bypass surgery. The study found that patients who received a biologic mesh had a significantly lower rate of developing an incisional hernia (2.3%) compared to those without mesh (17.7%). After adjusting for risk factors, placement of a biologic mesh was found to significantly reduce the risk of hernia, while smoking significantly increased the risk. The study suggests prophylactic use of biologic mesh may help reduce incisional hernia rates in high-risk patients.
1) The document describes a prototype endoscopic suturing system that allows full-thickness suturing of the stomach wall for closure of openings (gastrotomies) during natural orifice translumenal endoscopic surgery (NOTES).
2) In vitro tests on isolated pig stomachs showed the system could accurately place running sutures in a pursestring configuration to securely close an 18mm gastrotomy with no leaks.
3) Edge-to-edge closure of gastotomies was also achieved in a leak-proof manner during single intubations using the suturing system.
This document discusses the advantages of physician-led hospitals and why physicians must lead in healthcare. It provides examples showing that the top-rated hospitals like Mayo Clinic and Cleveland Clinic have been led by physicians for over 100 years. Physician leadership results in better patient outcomes, satisfaction, economic performance, and physician retention and satisfaction. Studies show physician-led hospitals score higher on quality metrics than non-clinician led hospitals. The document argues physicians possess credibility as leaders since they understand clinical practice from experience. It also discusses the challenges of physician burnout and need for training clinical leaders to succeed in today's team-based healthcare system.
This study evaluated the technical feasibility and safety of using a novel endoscopic suturing device to repair gastrointestinal fistulae in 7 patients. The procedure was technically successful in all patients with no early complications. At follow up of 5.1 months, 6 patients had resolution of symptoms and average weight loss of 22.8 pounds. While the study was limited by its small size and short follow up, the results suggest endoscopic repair of fistulae using this suturing device can be achieved safely and warrants further study.
This document summarizes the market for obesity products and treatments. It discusses how the field is moving "back to basics" to better understand the physiological mechanisms behind obesity and weight loss. This new understanding may help develop more effective minimally invasive solutions. The US market for minimally invasive bariatric devices is expected to grow moderately over the next five years, reaching over $500 million by 2016, driven by factors like the growing obese population. However, current treatment options have only achieved limited success in treating obesity.
This document provides details about an upcoming symposium on endosurgery to be held on September 19th, 2011 at the Apollo Hospital in New Delhi. The symposium will focus on flexible surgery techniques that minimize surgical trauma through natural orifices. Experts will present on robotics, endoscopic stitching and resection devices. The program will include training discussions on weight regain after bariatric surgery and a debate on surgical versus endoscopic solutions. Equipment demonstrations and a panel discussion on the future of endosurgery in India are also included. Attendees should include doctors from Apollo hospitals with expertise in gastroenterology, bariatrics, and endocrinology.
Flyer for one day seminar for surgeons and gastroenterologists showcasing innovative technologies in endosurgery and robotic surgery
Sept 19, 2011 New Delhi
This study examined whether placing a biologic mesh during abdominal closure would reduce the risk of developing an incisional hernia compared to primary closure without mesh in high-risk patients undergoing gastric bypass surgery. The study found that patients who received a biologic mesh had a significantly lower rate of developing an incisional hernia (2.3%) compared to those without mesh (17.7%). After adjusting for risk factors, placement of a biologic mesh was found to significantly reduce the risk of hernia, while smoking significantly increased the risk. The study suggests prophylactic use of biologic mesh may help reduce incisional hernia rates in high-risk patients.
1. The document discusses endoluminal procedures for weight regain after gastric bypass surgery, including endoluminal gastric pouch reduction (EGPR) and the ROSE procedure.
2. EGPR uses fasteners to narrow the gastric pouch and stoma, resulting in 10-20% excess weight loss typically. The ROSE procedure uses sutures to create folds in the pouch and around the stoma.
3. Studies found these procedures produced 12-25% excess weight loss on average and resolved issues like diarrhea and heartburn in many patients. However, long-term durability is still unknown and behavioral factors impact success.
The OverStitch Endoscopic Suturing System provides physicians the ability to perform running or interrupted stitches within the GI tract. The system is comprised of an Endoscopic Suturing System handle, End Cap, Anchor Exchange, and choice of absorbable or non-absorbable sutures. It is intended for endoscopic placement of sutures to approximate soft tissue and works by delivering anchors and sutures through the endoscope to place stitches. The system is contraindicated for use with malignant tissue or when general endoscopic techniques are contraindicated.
The OverStitch Endoscopic Suturing System allows physicians to perform full-thickness endoscopic suturing through a flexible endoscope in a manner similar to hand suturing. It can deploy both running and interrupted stitches with a single insertion of the endoscope. The system mimics the motion of a curved surgical needle and is designed for controlled suture placement. It is a single-use device available with absorbable or non-absorbable suture materials.
The American Society of General Surgeons (ASGS) supports the use of transoral fundoplication by trained surgeons as a treatment for chronic gastroesophageal reflux disease (GERD) in patients who do not get satisfactory relief from proton pump inhibitors or who wish to avoid lifelong medication dependence. The ASGS believes transoral fundoplication adheres to the same surgical principles as traditional fundoplication techniques by creating a full thickness wrap of the stomach around the esophagus. The ASGS position is supported by peer-reviewed literature demonstrating transoral fundoplication offers comparable results to open and laparoscopic surgery, with high patient satisfaction and relief of GERD symptoms.
Three recent studies published over the past four months involving nearly 200 patients in total provide additional evidence of the positive outcomes of transoral fundoplication (TIF) for the treatment of gastroesophageal reflux disease (GERD). The studies demonstrated a high therapeutic response rate with patients getting off daily proton pump inhibitors, significant response to objective reflux measurements, and a low complication rate of around 2%. The largest study to date involving 124 patients showed 75-80% of patients had normalized symptom scores and 97% were off daily PPI medications post-TIF. The growing body of clinical evidence supports TIF as a safe and effective alternative to traditional anti-reflux surgeries for appropriately selected GERD patients.
The document discusses a new treatment for chronic heartburn called EsophyX that is performed at Nuffield Health Leeds Hospital. It is a minimally invasive procedure that uses plastic fasteners to pull up stomach tissue and prevent acid reflux without surgery. The procedure provides relief for over 80% of symptoms and allows patients to greatly reduce or stop medication. One patient, Patrick Senycia, flew from Australia to receive the treatment and has experienced significant reduction in symptoms. The EsophyX procedure is pioneering as one of the most advanced treatments for chronic acid reflux worldwide.
The document discusses a new treatment for chronic heartburn called EsophyX that is performed at Nuffield Health Leeds Hospital. It is a minimally invasive procedure that uses plastic fasteners to pull up stomach tissue and prevent acid reflux without surgery. The procedure provides relief for over 80% of symptoms and allows patients to greatly reduce or stop medication. One patient, Patrick Senycia, flew from Australia to have the procedure done in Leeds and says his symptoms were greatly reduced. The EsophyX procedure is positioned as a promising new option for treating chronic acid reflux when medication is not effective.
Endoluminal procedures like EGPR and ROSE aim to treat weight regain after gastric bypass through minimally invasive techniques. EGPR uses tissue fasteners to reduce the gastric pouch size and narrow the stoma, resulting in 15.5 lb weight loss on average in 6 months. ROSE uses expandable anchors to similarly reduce pouch size and stoma diameter, stopping weight regain in 88% of patients. Both procedures appear safe and can produce near 50% loss of regained weight, though long-term durability is still unknown. Success may depend on factors like a patient's initial weight loss after gastric bypass.
The document describes an intragastric balloon system called Heliosphere BAG for the non-surgical treatment of obesity. It is a temporary balloon that is placed in the stomach for up to 6 months. Clinical studies showed it helped patients lose 9-24 kg on average and had good tolerance, with vomiting lasting less than 3 days for most patients. The balloon uses a patented gold coating process to maintain inflation volume over time and make extraction easier.
This document provides instructions for the implantation and extraction of an intragastric balloon called Heliosphere for the non-surgical treatment of obesity. The implantation procedure involves visually guiding the deflated balloon through the esophagus using an endoscope, then inflating it with saline to a specific volume in the stomach. For extraction, the balloon is first deflated by puncturing it and aspirating the air, then caught and pulled out through the esophagus using grasping forceps under endoscopic guidance. Safety and careful technique are emphasized to gradually pass the balloon through the esophagus and cardia during extraction.
The document describes an intragastric balloon system called Heliosphere BAG for the non-surgical treatment of obesity. It is a temporary balloon that is placed in the stomach for up to 6 months. Clinical studies showed it helped patients lose 9-24 kg on average and had good tolerance, with vomiting lasting less than 3 days for most patients. The balloon uses a patented gold coating process to maintain inflation volume over time and make extraction easier.
The document describes an intragastric balloon system called Heliosphere BAG for the non-surgical treatment of obesity. It is a temporary balloon that is placed in the stomach for up to 6 months. Clinical studies showed it helped patients lose 9-24 kg on average and had good tolerance, with vomiting lasting less than 3 days for most patients. The balloon uses a patented gold coating process to maintain inflation volume over time and make extraction easier.
This document provides contact information for Dr. Elliot Goodman in the Department of Surgery at a medical center, who has offices in Brooklyn and Manhattan. It notes that the week of November 21-27 is National GERD Awareness Week, and encourages learning more about treatment options.
A workshop hosted by the South African Journal of Science aimed at postgraduate students and early career researchers with little or no experience in writing and publishing journal articles.
1. The document discusses endoluminal procedures for weight regain after gastric bypass surgery, including endoluminal gastric pouch reduction (EGPR) and the ROSE procedure.
2. EGPR uses fasteners to narrow the gastric pouch and stoma, resulting in 10-20% excess weight loss typically. The ROSE procedure uses sutures to create folds in the pouch and around the stoma.
3. Studies found these procedures produced 12-25% excess weight loss on average and resolved issues like diarrhea and heartburn in many patients. However, long-term durability is still unknown and behavioral factors impact success.
The OverStitch Endoscopic Suturing System provides physicians the ability to perform running or interrupted stitches within the GI tract. The system is comprised of an Endoscopic Suturing System handle, End Cap, Anchor Exchange, and choice of absorbable or non-absorbable sutures. It is intended for endoscopic placement of sutures to approximate soft tissue and works by delivering anchors and sutures through the endoscope to place stitches. The system is contraindicated for use with malignant tissue or when general endoscopic techniques are contraindicated.
The OverStitch Endoscopic Suturing System allows physicians to perform full-thickness endoscopic suturing through a flexible endoscope in a manner similar to hand suturing. It can deploy both running and interrupted stitches with a single insertion of the endoscope. The system mimics the motion of a curved surgical needle and is designed for controlled suture placement. It is a single-use device available with absorbable or non-absorbable suture materials.
The American Society of General Surgeons (ASGS) supports the use of transoral fundoplication by trained surgeons as a treatment for chronic gastroesophageal reflux disease (GERD) in patients who do not get satisfactory relief from proton pump inhibitors or who wish to avoid lifelong medication dependence. The ASGS believes transoral fundoplication adheres to the same surgical principles as traditional fundoplication techniques by creating a full thickness wrap of the stomach around the esophagus. The ASGS position is supported by peer-reviewed literature demonstrating transoral fundoplication offers comparable results to open and laparoscopic surgery, with high patient satisfaction and relief of GERD symptoms.
Three recent studies published over the past four months involving nearly 200 patients in total provide additional evidence of the positive outcomes of transoral fundoplication (TIF) for the treatment of gastroesophageal reflux disease (GERD). The studies demonstrated a high therapeutic response rate with patients getting off daily proton pump inhibitors, significant response to objective reflux measurements, and a low complication rate of around 2%. The largest study to date involving 124 patients showed 75-80% of patients had normalized symptom scores and 97% were off daily PPI medications post-TIF. The growing body of clinical evidence supports TIF as a safe and effective alternative to traditional anti-reflux surgeries for appropriately selected GERD patients.
The document discusses a new treatment for chronic heartburn called EsophyX that is performed at Nuffield Health Leeds Hospital. It is a minimally invasive procedure that uses plastic fasteners to pull up stomach tissue and prevent acid reflux without surgery. The procedure provides relief for over 80% of symptoms and allows patients to greatly reduce or stop medication. One patient, Patrick Senycia, flew from Australia to receive the treatment and has experienced significant reduction in symptoms. The EsophyX procedure is pioneering as one of the most advanced treatments for chronic acid reflux worldwide.
The document discusses a new treatment for chronic heartburn called EsophyX that is performed at Nuffield Health Leeds Hospital. It is a minimally invasive procedure that uses plastic fasteners to pull up stomach tissue and prevent acid reflux without surgery. The procedure provides relief for over 80% of symptoms and allows patients to greatly reduce or stop medication. One patient, Patrick Senycia, flew from Australia to have the procedure done in Leeds and says his symptoms were greatly reduced. The EsophyX procedure is positioned as a promising new option for treating chronic acid reflux when medication is not effective.
Endoluminal procedures like EGPR and ROSE aim to treat weight regain after gastric bypass through minimally invasive techniques. EGPR uses tissue fasteners to reduce the gastric pouch size and narrow the stoma, resulting in 15.5 lb weight loss on average in 6 months. ROSE uses expandable anchors to similarly reduce pouch size and stoma diameter, stopping weight regain in 88% of patients. Both procedures appear safe and can produce near 50% loss of regained weight, though long-term durability is still unknown. Success may depend on factors like a patient's initial weight loss after gastric bypass.
The document describes an intragastric balloon system called Heliosphere BAG for the non-surgical treatment of obesity. It is a temporary balloon that is placed in the stomach for up to 6 months. Clinical studies showed it helped patients lose 9-24 kg on average and had good tolerance, with vomiting lasting less than 3 days for most patients. The balloon uses a patented gold coating process to maintain inflation volume over time and make extraction easier.
This document provides instructions for the implantation and extraction of an intragastric balloon called Heliosphere for the non-surgical treatment of obesity. The implantation procedure involves visually guiding the deflated balloon through the esophagus using an endoscope, then inflating it with saline to a specific volume in the stomach. For extraction, the balloon is first deflated by puncturing it and aspirating the air, then caught and pulled out through the esophagus using grasping forceps under endoscopic guidance. Safety and careful technique are emphasized to gradually pass the balloon through the esophagus and cardia during extraction.
The document describes an intragastric balloon system called Heliosphere BAG for the non-surgical treatment of obesity. It is a temporary balloon that is placed in the stomach for up to 6 months. Clinical studies showed it helped patients lose 9-24 kg on average and had good tolerance, with vomiting lasting less than 3 days for most patients. The balloon uses a patented gold coating process to maintain inflation volume over time and make extraction easier.
The document describes an intragastric balloon system called Heliosphere BAG for the non-surgical treatment of obesity. It is a temporary balloon that is placed in the stomach for up to 6 months. Clinical studies showed it helped patients lose 9-24 kg on average and had good tolerance, with vomiting lasting less than 3 days for most patients. The balloon uses a patented gold coating process to maintain inflation volume over time and make extraction easier.
This document provides contact information for Dr. Elliot Goodman in the Department of Surgery at a medical center, who has offices in Brooklyn and Manhattan. It notes that the week of November 21-27 is National GERD Awareness Week, and encourages learning more about treatment options.
A workshop hosted by the South African Journal of Science aimed at postgraduate students and early career researchers with little or no experience in writing and publishing journal articles.
This presentation was provided by Steph Pollock of The American Psychological Association’s Journals Program, and Damita Snow, of The American Society of Civil Engineers (ASCE), for the initial session of NISO's 2024 Training Series "DEIA in the Scholarly Landscape." Session One: 'Setting Expectations: a DEIA Primer,' was held June 6, 2024.
Leveraging Generative AI to Drive Nonprofit InnovationTechSoup
In this webinar, participants learned how to utilize Generative AI to streamline operations and elevate member engagement. Amazon Web Service experts provided a customer specific use cases and dived into low/no-code tools that are quick and easy to deploy through Amazon Web Service (AWS.)
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...PECB
Denis is a dynamic and results-driven Chief Information Officer (CIO) with a distinguished career spanning information systems analysis and technical project management. With a proven track record of spearheading the design and delivery of cutting-edge Information Management solutions, he has consistently elevated business operations, streamlined reporting functions, and maximized process efficiency.
Certified as an ISO/IEC 27001: Information Security Management Systems (ISMS) Lead Implementer, Data Protection Officer, and Cyber Risks Analyst, Denis brings a heightened focus on data security, privacy, and cyber resilience to every endeavor.
His expertise extends across a diverse spectrum of reporting, database, and web development applications, underpinned by an exceptional grasp of data storage and virtualization technologies. His proficiency in application testing, database administration, and data cleansing ensures seamless execution of complex projects.
What sets Denis apart is his comprehensive understanding of Business and Systems Analysis technologies, honed through involvement in all phases of the Software Development Lifecycle (SDLC). From meticulous requirements gathering to precise analysis, innovative design, rigorous development, thorough testing, and successful implementation, he has consistently delivered exceptional results.
Throughout his career, he has taken on multifaceted roles, from leading technical project management teams to owning solutions that drive operational excellence. His conscientious and proactive approach is unwavering, whether he is working independently or collaboratively within a team. His ability to connect with colleagues on a personal level underscores his commitment to fostering a harmonious and productive workplace environment.
Date: May 29, 2024
Tags: Information Security, ISO/IEC 27001, ISO/IEC 42001, Artificial Intelligence, GDPR
-------------------------------------------------------------------------------
Find out more about ISO training and certification services
Training: ISO/IEC 27001 Information Security Management System - EN | PECB
ISO/IEC 42001 Artificial Intelligence Management System - EN | PECB
General Data Protection Regulation (GDPR) - Training Courses - EN | PECB
Webinars: https://pecb.com/webinars
Article: https://pecb.com/article
-------------------------------------------------------------------------------
For more information about PECB:
Website: https://pecb.com/
LinkedIn: https://www.linkedin.com/company/pecb/
Facebook: https://www.facebook.com/PECBInternational/
Slideshare: http://www.slideshare.net/PECBCERTIFICATION
it describes the bony anatomy including the femoral head , acetabulum, labrum . also discusses the capsule , ligaments . muscle that act on the hip joint and the range of motion are outlined. factors affecting hip joint stability and weight transmission through the joint are summarized.
Walmart Business+ and Spark Good for Nonprofits.pdfTechSoup
"Learn about all the ways Walmart supports nonprofit organizations.
You will hear from Liz Willett, the Head of Nonprofits, and hear about what Walmart is doing to help nonprofits, including Walmart Business and Spark Good. Walmart Business+ is a new offer for nonprofits that offers discounts and also streamlines nonprofits order and expense tracking, saving time and money.
The webinar may also give some examples on how nonprofits can best leverage Walmart Business+.
The event will cover the following::
Walmart Business + (https://business.walmart.com/plus) is a new shopping experience for nonprofits, schools, and local business customers that connects an exclusive online shopping experience to stores. Benefits include free delivery and shipping, a 'Spend Analytics” feature, special discounts, deals and tax-exempt shopping.
Special TechSoup offer for a free 180 days membership, and up to $150 in discounts on eligible orders.
Spark Good (walmart.com/sparkgood) is a charitable platform that enables nonprofits to receive donations directly from customers and associates.
Answers about how you can do more with Walmart!"
This slide is special for master students (MIBS & MIFB) in UUM. Also useful for readers who are interested in the topic of contemporary Islamic banking.
Strategies for Effective Upskilling is a presentation by Chinwendu Peace in a Your Skill Boost Masterclass organisation by the Excellence Foundation for South Sudan on 08th and 09th June 2024 from 1 PM to 3 PM on each day.
How to Add Chatter in the odoo 17 ERP ModuleCeline George
In Odoo, the chatter is like a chat tool that helps you work together on records. You can leave notes and track things, making it easier to talk with your team and partners. Inside chatter, all communication history, activity, and changes will be displayed.
This presentation includes basic of PCOS their pathology and treatment and also Ayurveda correlation of PCOS and Ayurvedic line of treatment mentioned in classics.